Jazz: 2Q Earnings Snapshot
DUBLIN (AP) _ Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported second-quarter earnings of $261.9 million.
On a per-share basis, the Dublin-based company said it had profit of $4.56. Earnings, adjusted for one-time gains and costs, were $4.05 per share.
The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.57 per share.
The drugmaker posted revenue of $534.1 million in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $508.3 million.
Jazz expects full-year earnings in the range of $14.30 to $15 per share, with revenue in the range of $2.07 billion to $2.15 billion.
Jazz shares have increased 14% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $141.16, a decrease of 20% in the last 12 months.